Olanzapine-induced leucopenia and neutropenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 29, Issue 6, 2005, Pages 992-994

  Stergiou, Vasilis ^a   Bozikas, Vasilis P ^a,b   Garyfallos, George ^a   Nikolaidis, Nikolas ^a   Lavrentiadis, Grigoris ^a   Fokas, Kostas ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NONE   (Greece)

Author keywords

Leucopenia; Neutropenia; Olanzapine

Indexed keywords

CITALOPRAM; LORAZEPAM; OLANZAPINE; RISPERIDONE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; LEUKOPENIA; MAJOR DEPRESSION; MALE; NEUTROPENIA; RISK ASSESSMENT;

AGED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DEPRESSIVE DISORDER, MAJOR; HUMANS; LEUKOPENIA; MALE; NEUTROPENIA;

EID: 23144445329     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2005.04.025     Document Type: Article

References (20)

1. J.C. Ballenger Benzodiazpine receptor agonists and antagonists B.J. Sadock V. Sadock Kaplan and Sadocks Comprehensive Textbook of Psychiatry 7th edition 2000 Lippincott Williams and Wilkins Philadelphia 2317 2324
2. T.R.E. Barnes, and M.A. McPhillips Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics Br. J. Psychiatry 174 Suppl. 38 1999 34 43
3. F. Benedetti, R. Cavallaro, and E. Smeraldi Olanzapine-induced neutropenia Lancet 354 1999 567
4. N. Clark, E. Weissberg, and J. Noel Quetiapine and leukopenia Am. J. Psychiatry 158 2001 817 818
5. Z. Dernovsek, and R. Tavcar Risperidone-induced leucopenia and neutropenia Br. J. Psychiatry 171 1997 393 394
6. M. Dettling, I. Cascorbi, R. Hellweg, U. Deicke, L. Weise, and B. Müller-Oerlinghausen Genetic determinants of drug-induced agranulocytosis: potential risk of olanzapine? Pharmacopsychiatry 32 1999 110 112
7. B. Finkel, A.G. Lerner, I. Oyffe, and M. Sigal Risperidone-associated agranulocytosis Am. J. Psychiatry 155 1998 855 856
8. P. Gajwani, and G.E. Tesar Olanzapine-induced neutropenia Psychosomatics 41 2000 150 151
9. I. Guest, and J. Uetrecht Drugs that induce neutropenia/agranulocytosis may target specific components of the stromal cell extracellular matrix Med. Hypotheses 53 1999 145 151
10. X. Hong, and X. Wang Agranulocytosis and neutropenia with typical and atypical neuroleptics Am. J. Psychiatry 158 2001 1736 1737
11. J.E. Kesley, and C.B. Nemeroff Citalopram B.J. Sadock V. Sadock Kaplan and Sadocks Comprehensive Textbook of Psychiatry 7th edition 2000 Lippincott Williams and Wilkins Philadelphia 2435 2438
12. W. Meissner, T. Schmidt, A. Kupsch, T. Trottenberg, and T. Lembert Reversible leukopenia related to olanzapine Mov. Disord. 5 1999 872 873
13. R. Naumann, W. Felber, H. Heilemann, and T. Renster Olanzapine-induced agranulocytosis Lancet 354 1999 556 557
14. O. Oluboka, D. Haslam, T. Lam, D. Bown-Demaro, and N. Bay Quetiapine-induced leucopenia: possible dosage-related phenomenon Can. J. Psychiatry 48 2003 65 66
15. G. Ruhé Henricus, E. Becker Hiske, P. Jessurun, C.H. Marees, M. Heeringa, and H.D.B. Vermeulen Agranulocytosis and granulocytopenia associated with quetiapine Acta Psychiatr. Scand. 104 2001 311 314
16. A. Schuld, T. Kraus, D. Hinze-Selch, M. Haack, and T. Pollmaecher Granulocyte colony-stimulating factor plasma levels during clozapine and olanzapine-induced granulocytopenia Acta Psychiatr. Scand. 102 2000 153 155
17. M. Sluys, Y. Güzelcan, G. Casteelen, and L. de Haan Risperidone-induced leucopenia and neutropenia: a case report Eur. Psychiatr. 19 2004 117
18. S.M. Stahl Essential Psychopharmacology 2nd ed. 2000 Cambridge University Press New York
19. A. Steinwachs, R. Grohmann, F. Pedrosa, E. Rüther, and I. Schwerdtner Two cases of olanzapine-induced reversible neutropenia Pharmacopsychiatry 32 1999 154 156
20. C. Tolosa-Vilella, A. Ruiz-Ripoll, B. Mari-Alfonso, and E. Naval-Sendra Olanzapine-induced agranulocytosis. A case report and review of the literature Prog. Neuro-Psychopharmacol. Biol. Psychiatry 26 2002 411 417